Cumberland Pharmaceuticals (CPIX) Change in Acquisitions & Divestments (2012 - 2023)
Cumberland Pharmaceuticals (CPIX) reported Change in Acquisitions & Divestments of $347356.0 for Q4 2023, up 273.68% sequentially from -$200000.0 in Q1 2021.
Cumberland Pharmaceuticals (CPIX) Change in Acquisitions & Divestments (2012 - 2023) Analysis & Trends
Cumberland Pharmaceuticals (CPIX) has 11 years of Change in Acquisitions & Divestments data on file, last reported at $347356.0 in Q4 2023.
- For the quarter ending Q4 2023, Change in Acquisitions & Divestments changed N/A year-over-year to $347356.0; the trailing twelve-month figure through Dec 2025 stood at $347356.0 (changed 0.0% YoY), and the FY2024 full-year result was $237556.0, down 31.61% from the prior year.
- Change in Acquisitions & Divestments climbed to $347356.0 in Q4 2023, from -$200000.0 in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $20.1 million in Q4 2019 to a low of -$8.6 million in Q3 2019.
- A 4-year average of $3.0 million and a median of $460888.0 in 2020 frame the typical range for Change in Acquisitions & Divestments.
- Across the five-year window, Change in Acquisitions & Divestments slumped 192.9% in 2019 and soared 105.38% in 2020, its largest moves.
- Tracing CPIX's Change in Acquisitions & Divestments over 4 years: stood at $20.1 million in 2019, then slumped by 97.7% to $460888.0 in 2020, then sank by 143.39% to -$200000.0 in 2021, then jumped by 273.68% to $347356.0 in 2023.
- Business Quant data shows CPIX's Change in Acquisitions & Divestments at $347356.0 in Q4 2023, -$200000.0 in Q1 2021, and $460888.0 in Q3 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.46 Bn | 87.60 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.93 Bn | 32.19 Bn | 1.97 Bn |
| 3 | Zoetis | 32.54 Bn | 30.60 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.05 Bn | 20.89 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.24 Bn | 18.43 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.45 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.60 Bn | 12.17 Bn | 785.00 Mn |
| 10 | Cumberland Pharmaceuticals | 101.58 Mn | 90.57 Mn | 7.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 347,356.00 |
| Dec 31, 2023 | 347,356.00 |
| Mar 31, 2021 | -200,000.00 |
| Mar 31, 2021 | -200,000.00 |
| Sep 30, 2020 | 460,888.00 |
| Sep 30, 2020 | 460,888.00 |
| Dec 31, 2019 | 20.06 Mn |
| Dec 31, 2019 | 20.06 Mn |
| Sep 30, 2019 | -8.56 Mn |
| Sep 30, 2019 | -8.56 Mn |
| Jun 30, 2019 | 2.08 Mn |
| Jun 30, 2019 | 2.08 Mn |
| Mar 31, 2019 | 6.48 Mn |
| Mar 31, 2019 | 6.48 Mn |
| Sep 30, 2018 | 9.22 Mn |
| Sep 30, 2018 | 9.22 Mn |
| Jun 30, 2018 | 2.65 Mn |
| Jun 30, 2018 | 2.65 Mn |
| Mar 31, 2018 | 4.26 Mn |
| Mar 31, 2018 | 4.26 Mn |